加拿大儿童循环性死亡判定后器官捐献临床实践指南摘要报告
本指南由加拿大采用世界卫生组织与加拿大医学会方法、按GRADE体系制定,聚焦儿童循环性死亡判定后器官捐献(DCD)。问题来源于2006年加拿大DCD指南(非儿科特异)、全国及国际儿科DCD多学科研讨会和儿科DCD文献范围综述,并对所有可操作问题补充文献复习。最终形成63条良好实践声明和7条GRADE推荐,覆盖伦理与知情同意及撤除生命维持治疗、资格、撤除生命维持治疗实践、死前与死后干预、死亡判定、新生儿儿科DCD、心脏与创新性儿科DCD及实施共8个领域。摘要报告为简洁仅纳入48条良好实践声明及删节版理由,其余推荐、详细方法、完整GRADE表与扩展理由见全文报告。作者认为严格透明的指南制定在儿童逝后捐献领域可行,应用这些推荐将增加加拿大儿童DCD的可及性,并可能为逝后捐献领域未来指南制定提供范本。
要点
- 指南覆盖8个领域:伦理与知情同意及撤除生命维持治疗、资格、撤除生命维持治疗实践、死前与死后干预、死亡判定、新生儿DCD、心脏与创新性DCD、实施。
- 共形成63条良好实践声明和7条GRADE推荐;摘要报告为简洁仅纳入其中48条良好实践声明及删节版理由,其余内容见全文报告。
- 制定方法基于世界卫生组织与加拿大医学会方法,采用GRADE分级,并经七个专题工作组共识及儿科、重症监护和重症监护护理专业学会与患者伙伴外部评审。
- 推荐问题来源于2006年加拿大DCD指南(非儿科特异)、全国及国际儿科DCD多学科研讨会、儿科DCD文献范围综述,并对所有可操作问题补充文献复习。
- 作者认为严格透明的指南制定在儿童逝后捐献领域可行,应用这些推荐将增加加拿大儿童DCD的可及性,并可能为逝后捐献领域未来指南制定提供范本。
适用人群与场景
- 加拿大儿童循环性死亡判定后器官捐献(DCD)的适用人群与场景,涉及伦理与知情同意、撤除生命维持治疗、资格评估、死前与死后干预、死亡判定、新生儿DCD、心脏与创新性DCD及实施等8个领域
研究设计与关键结果
- 指南制定方法基于世界卫生组织与加拿大医学会方法,采用GRADE分级;推荐问题由2006年加拿大DCD指南(非儿科特异)、全国及国际儿科DCD多学科研讨会、儿科DCD文献范围综述三方面来源生成,并对所有可操作问题补充文献复习。
- 最终形成63条良好实践声明和7条GRADE推荐,覆盖伦理与知情同意及撤除生命维持治疗、资格、撤除生命维持治疗实践、死前与死后干预、死亡判定、新生儿DCD、心脏与创新性DCD、实施共8个领域。
- 摘要报告为简洁仅纳入48条良好实践声明及删节版理由,其余推荐、详细方法、完整GRADE表与扩展理由见全文报告。
- 推荐经七个专题工作组成员共识修订,并在工作组负责人与规划委员会会议上定稿,由儿科、重症监护和重症监护护理专业学会及患者伙伴提供外部评审。
证据类型、等级与局限
- 证据类型:临床实践指南(指南/共识);采用GRADE方法评估证据质量并通过证据到决策框架形成推荐,同时制定GRADE良好实践声明;推荐经七个专题工作组共识及外部评审。
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为严格透明的临床实践指南制定在儿童逝后捐献领域可行;应用这些推荐将增加加拿大儿童DCD的可及性,并可能为逝后捐献领域未来指南制定提供范本。
指南或共识出处
- 加拿大儿童循环性死亡判定后器官捐献指南摘要报告(Canadian Guidelines for Controlled Pediatric Donation After Circulatory Determination of Death-Summary Report),发表于Pediatr Crit Care Med
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Create trustworthy, rigorous, national clinical practice guidelines for the practice of pediatric donation after circulatory determination of death in Canada.
METHODS: We followed a process of clinical practice guideline development based on World Health Organization and Canadian Medical Association methods. This included application of Grading of Recommendations Assessment, Development, and Evaluation methodology. Questions requiring recommendations were generated based on 1) 2006 Canadian donation after circulatory determination of death guidelines (not pediatric specific), 2) a multidisciplinary symposium of national and international pediatric donation after circulatory determination of death leaders, and 3) a scoping review of the pediatric donation after circulatory determination of death literature. Input from these sources drove drafting of actionable questions and Good Practice Statements, as defined by the Grading of Recommendations Assessment, Development, and Evaluation group. We performed additional literature reviews for all actionable questions. Evidence was assessed for quality using Grading of Recommendations Assessment, Development, and Evaluation and then formulated into evidence profiles that informed recommendations through the evidence-to-decision framework. Recommendations were revised through consensus among members of seven topic-specific working groups and finalized during meetings of working group leads and the planning committee. External review was provided by pediatric, critical care, and critical care nursing professional societies and patient partners.
RESULTS: We generated 63 Good Practice Statements and seven Grading of Recommendations Assessment, Development, and Evaluation recommendations covering 1) ethics, consent, and withdrawal of life-sustaining therapy, 2) eligibility, 3) withdrawal of life-sustaining therapy practices, 4) ante and postmortem interventions, 5) death determination, 6) neonatal pediatric donation after circulatory determination of death, 7) cardiac and innovative pediatric donation after circulatory determination of death, and 8) implementation. For brevity, 48 Good Practice Statement and truncated justification are included in this summary report. The remaining recommendations, detailed methodology, full Grading of Recommendations Assessment, Development, and Evaluation tables, and expanded justifications are available in the full text report.
CONCLUSIONS: This process showed that rigorous, transparent clinical practice guideline development is possible in the domain of pediatric deceased donation. Application of these recommendations will increase access to pediatric donation after circulatory determination of death across Canada and may serve as a model for future clinical practice guideline development in deceased donation.
参考来源
- Weiss MJ, Hornby L, Rochwerg B, et al. Canadian Guidelines for Controlled Pediatric Donation After Circulatory Determination of Death-Summary Report. Pediatr Crit Care Med. 2017. PMID: 28925929. doi:10.1097/PCC.0000000000001320
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。